Patients with Breast Disorders Flashcards
adjuvant chemotherapy:
the use of anticancer medications in addition to other treatments to delay or prevent a recurrence of the disease
adjuvant hormonal therapy:
the use of synthetic hormones or other medications given after primary treatment to increase the chances of a cure by stopping or slowing the growth of certain cancers that are affected by hormone stimulation (sometimes called endocrine or antiestrogen therapy)
aromatase inhibitors:
medications that block the production of estrogens by the adrenal glands
atypical hyperplasia:
abnormal increase in the number of cells in a specific area within the ductal or lobular areas of the breast; this abnormal proliferation increases the risk for cancer
benign proliferative breast disease:
various types of atypical, yet noncancerous, breast tissue that increase the risk of breast cancer
brachytherapy:
delivery of radiation therapy through internal implants to a localized area of tissue
BRCA1 and BRCA2:
genes on chromosome 17 that, when damaged or mutated, increase a woman’s risk for breast and/or ovarian cancer compared with women without the mutation
breast conservation treatment:
surgery to remove a breast tumor and a margin of tissue around the tumor without removing any other part of the breast; may or may not include lymph node removal and radiation therapy
dose-dense chemotherapy:
administration of chemotherapeutic agents at standard doses with shorter time intervals between each cycle of treatment
ductal carcinoma in situ (DCIS):
cancer cells starting in the ductal system of the breast but not penetrating surrounding tissue
fibrocystic breast changes:
term used to describe certain benign changes in the breast, typically palpable nodularity, lumpiness, swelling, or pain
fine-needle aspiration (FNA):
removal of fluid for diagnostic analysis from a cyst or cells from a mass using a needle and syringe
gynecomastia:
firm, overdeveloped breast tissue typically seen in adolescent boys
HER-2/neu:
a protein, when found in larger amounts, indicates an aggressive tumor
lobular carcinoma in situ (LCIS):
atypical change and proliferation of the lobular cells of the breast